Differences in Topography of Individual Amyloid Brain Networks by Amyloid PET Images in Healthy Control, Mild Cognitive Impairment, and Alzheimer's Disease

Amyloid plaques, implicated in Alzheimer's disease, exhibit a spatial propagation pattern through interconnected brain regions, suggesting network-driven dissemination. This study utilizes PET imaging to investigate these brain connections and introduces an innovative method for analyzing the amyloid network. A modified version of a previously established method is applied to explore distinctive patterns of connectivity alterations across cognitive performance domains. PET images illustrate differences in amyloid accumulation, complemented by quantitative network indices. The normal control group shows minimal amyloid accumulation and preserved network connectivity. The MCI group displays intermediate amyloid deposits and partial similarity to normal controls and AD patients, reflecting the evolving nature of cognitive decline. Alzheimer's disease patients exhibit high amyloid levels and pronounced disruptions in network connectivity, which are reflected in low levels of global efficiency (Eg) and local efficiency (Eloc). It is mostly in the temporal lobe where connectivity alterations are found, particularly in regions related to memory and cognition. Network connectivity alterations, combined with amyloid PET imaging, show potential as discriminative markers for different cognitive states. Dataset-specific variations must be considered when interpreting connectivity patterns. The variability in MCI and AD overlap emphasizes the heterogeneity in cognitive decline progression, suggesting personalized approaches for neurodegenerative disorders. This study contributes to understanding the evolving network characteristics associated with normal cognition, MCI, and AD, offering valuable insights for developing diagnostic and prognostic markers.

Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson's disease: a systematic review and meta-analysis

Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the diagnosis of Parkinson's disease (PD). We aim to systematically review the diagnostic accuracy of AI-assisted PET in detecting PD. The Ovid MEDLINE, Ovid Embase, Web of Science, and IEEE Xplore databases were systematically searched for related studies that developed an AI algorithm in PET imaging for diagnostic performance from PD and were published by August 17, 2023. Binary diagnostic accuracy data were extracted for meta-analysis to derive outcomes of interest: area under the curve (AUC). 23 eligible studies provided sufficient data to construct contingency tables that allowed the calculation of diagnostic accuracy. Specifically, 11 studies were identified that distinguished PD from normal control, with a pooled AUC of 0.96 (95% CI: 0.94-0.97) for presynaptic dopamine (DA) and 0.90 (95% CI: 0.87-0.93) for glucose metabolism (18F-FDG). 13 studies were identified that distinguished PD from the atypical parkinsonism (AP), with a pooled AUC of 0.93 (95% CI: 0.91 - 0.95) for presynaptic DA, 0.79 (95% CI: 0.75-0.82) for postsynaptic DA, and 0.97 (95% CI: 0.96-0.99) for 18F-FDG. Acceptable diagnostic performance of PD with AI algorithms-assisted PET imaging was highlighted across the subgroups. More rigorous reporting standards that take into account the unique challenges of AI research could improve future studies.

Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease

Network analysis of functional brain scans acquired with [18F]-fluorodeoxyglucose positron emission tomography (FDG PET, to map cerebral glucose metabolism), or resting-state functional magnetic resonance imaging (rs-fMRI, to map blood oxygen level-dependent brain activity) has increasingly been used to identify and validate reproducible circuit abnormalities associated with neurodegenerative disorders such as Parkinson's disease (PD). In addition to serving as imaging markers of the underlying disease process, these networks can be used singly or in combination as an adjunct to clinical diagnosis and as a screening tool for therapeutics trials. Disease networks can also be used to measure rates of progression in natural history studies and to assess treatment responses in individual subjects. Recent imaging studies in PD subjects scanned before and after treatment have revealed therapeutic effects beyond the modulation of established disease networks. Rather, other mechanisms of action may be at play, such as the induction of novel functional brain networks directly by treatment. To date, specific treatment-induced networks have been described in association with novel interventions for PD such as subthalamic adeno-associated virus glutamic acid decarboxylase (AAV2-GAD) gene therapy, as well as sham surgery or oral placebo under blinded conditions. Indeed, changes in the expression of these networks with treatment have been found to correlate consistently with clinical outcome. In aggregate, these attributes suggest a role for functional brain networks as biomarkers in future clinical trials.

Electrical Stimulation Induced Current Distribution in Peripheral Nerves Varies Significantly with the Extent of Nerve Damage: A Computational Study Utilizing Convolutional Neural Network and Realistic Nerve Models

Electrical stimulation of the peripheral nervous system is a promising therapeutic option for several conditions; however, its effects on tissue and the safety of the stimulation remain poorly understood. In order to devise stimulation protocols that enhance therapeutic efficacy without the risk of causing tissue damage, we constructed computational models of peripheral nerve and stimulation cuffs based on extremely high-resolution cross-sectional images of the nerves using the most recent advances in computing power and machine learning techniques. We developed nerve models using nonstimulated (healthy) and over-stimulated (damaged) rat sciatic nerves to explore how nerve damage affects the induced current density distribution. Using our in-house computational, quasi-static, platform, and the Admittance Method (AM), we estimated the induced current distribution within the nerves and compared it for healthy and damaged nerves. We also estimated the extent of localized cell damage in both healthy and damaged nerve samples. When the nerve is damaged, as demonstrated principally by the decreased nerve fiber packing, the current penetrates deeper into the over-stimulated nerve than in the healthy sample. As safety limits for electrical stimulation of peripheral nerves still refer to the Shannon criterion to distinguish between safe and unsafe stimulation, the capability this work demonstrated is an important step toward the development of safety criteria that are specific to peripheral nerve and make use of the latest advances in computational bioelectromagnetics and machine learning, such as Python-based AM and CNN-based nerve image segmentation.

Functional brain networks in the evaluation of patients with neurodegenerative disorders

Network analytical tools are increasingly being applied to brain imaging maps of resting metabolic activity (PET) or blood oxygenation-dependent signals (functional MRI) to characterize the abnormal neural circuitry that underlies brain diseases. This approach is particularly valuable for the study of neurodegenerative disorders, which are characterized by stereotyped spread of pathology along discrete neural pathways. Identification and validation of disease-specific brain networks facilitate the quantitative assessment of pathway changes over time and during the course of treatment. Network abnormalities can often be identified before symptom onset and can be used to track disease progression even in the preclinical period. Likewise, network activity can be modulated by treatment and might therefore be used as a marker of efficacy in clinical trials. Finally, early differential diagnosis can be achieved by simultaneously measuring the activity levels of multiple disease networks in an individual patient's scans. Although these techniques were originally developed for PET, over the past several years analogous methods have been introduced for functional MRI, a more accessible non-invasive imaging modality. This advance is expected to broaden the application of network tools to large and diverse patient populations.

Machine learning for autism spectrum disorder diagnosis using structural magnetic resonance imaging: Promising but challenging

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that affects approximately 1% of the population and causes significant burdens. ASD's pathogenesis remains elusive; hence, diagnosis is based on a constellation of behaviors. Structural magnetic resonance imaging (sMRI) studies have shown several abnormalities in volumetric and geometric features of the autistic brain. However, inconsistent findings prevented most contributions from being translated into clinical practice. Establishing reliable biomarkers for ASD using sMRI is crucial for the correct diagnosis and treatment. In recent years, machine learning (ML) and specifically deep learning (DL) have quickly extended to almost every sector, notably in disease diagnosis. Thus, this has led to a shift and improvement in ASD diagnostic methods, fulfilling most clinical diagnostic requirements. However, ASD discovery remains difficult. This review examines the ML-based ASD diagnosis literature over the past 5 years. A literature-based taxonomy of the research landscape has been mapped, and the major aspects of this topic have been covered. First, we provide an overview of ML's general classification pipeline and the features of sMRI. Next, representative studies are highlighted and discussed in detail with respect to methods, and biomarkers. Finally, we highlight many common challenges and make recommendations for future directions. In short, the limited sample size was the main obstacle; Thus, comprehensive data sets and rigorous methods are necessary to check the generalizability of the results. ML technologies are expected to advance significantly in the coming years, contributing to the diagnosis of ASD and helping clinicians soon.

Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?

Highlights

Abstract

Neurodegenerative parkinsonian disorders are characterized by a great diversity of clinical symptoms and underlying neuropathology, yet differential diagnosis during lifetime remains probabilistic. Molecular imaging is a powerful method to detect pathological changes in vivo on a cellular and molecular level with high specificity. Thereby, molecular imaging enables to investigate functional changes and pathological hallmarks in neurodegenerative disorders, thus allowing to better differentiate between different forms of degenerative parkinsonism, improve the accuracy of the clinical diagnosis and disentangle the pathophysiology of disease-related symptoms. The past decade led to significant progress in the field of molecular imaging, including the development of multiple new and promising radioactive tracers for single photon emission computed tomography (SPECT) and positron emission tomography (PET) as well as novel analytical methods. Here, we review the most recent advances in molecular imaging for the diagnosis, prognosis, and mechanistic understanding of parkinsonian disorders. First, advances in imaging of neurotransmission abnormalities, metabolism, synaptic density, inflammation, and pathological protein aggregation are reviewed, highlighting our renewed understanding regarding the multiplicity of neurodegenerative processes involved in parkinsonian disorders. Consequently, we review the role of molecular imaging in the context of disease-modifying interventions to follow neurodegeneration, ensure stratification, and target engagement in clinical trials.

Towards Secure and Intelligent Internet of Health Things: A Survey of Enabling Technologies and Applications

With the growth of computing and communication technologies, the information processing paradigm of the healthcare environment is evolving. The patient information is stored electronically, making it convenient to store and retrieve patient information remotely when needed. However, evolving the healthcare systems into smart healthcare environments comes with challenges and additional pressures. Internet of Things (IoT) connects things, such as computing devices, through wired or wireless mediums to form a network. There are numerous security vulnerabilities and risks in the existing IoT-based systems due to the lack of intrinsic security technologies. For example, patient medical data, data privacy, data sharing, and convenience are considered imperative for collecting and storing electronic health records (EHR). However, the traditional IoT-based EHR systems cannot deal with these paradigms because of inconsistent security policies and data access structures. Blockchain (BC) technology is a decentralized and distributed ledger that comes in handy in storing patient data and encountering data integrity and confidentiality challenges. Therefore, it is a viable solution for addressing existing IoT data security and privacy challenges. BC paves a tremendous path to revolutionize traditional IoT systems by enhancing data security, privacy, and transparency. The scientific community has shown a variety of healthcare applications based on artificial intelligence (AI) that improve health diagnosis and monitoring practices. Moreover, technology companies and startups are revolutionizing healthcare with AI and related technologies. This study illustrates the implication of integrated technologies based on BC, IoT, and AI to meet growing healthcare challenges. This research study examines the integration of BC technology with IoT and analyzes the advancements of these innovative paradigms in the healthcare sector. In addition, our research study presents a detailed survey on enabling technologies for the futuristic, intelligent, and secure internet of health things (IoHT). Furthermore, this study comprehensively studies the peculiarities of the IoHT environment and the security, performance, and progression of the enabling technologies. First, the research gaps are identified by mapping security and performance benefits inferred by the BC technologies. Secondly, practical issues related to the integration process of BC and IoT devices are discussed. Third, the healthcare applications integrating IoT, BC, and ML in healthcare environments are discussed. Finally, the research gaps, future directions, and limitations of the enabling technologies are discussed.

Quantifying Differences Between Affine and Nonlinear Spatial Normalization of FP-CIT Spect Images

Spatial normalization helps us to compare quantitatively two or more input brain scans. Although using an affine normalization approach preserves the anatomical structures, the neuroimaging field is more common to find works that make use of nonlinear transformations. The main reason is that they facilitate a voxel-wise comparison, not only when studying functional images but also when comparing MRI scans given that they fit better to a reference template. However, the amount of bias introduced by the nonlinear transformations can potentially alter the final outcome of a diagnosis especially when studying functional scans for neurological disorders like Parkinson's Disease. In this context, we have tried to quantify the bias introduced by the affine and the nonlinear spatial registration of FP-CIT SPECT volumes of healthy control subjects and patients with PD. For that purpose, we calculated the deformation fields of each participant and applied these deformation fields to a 3D-grid. As the space between the edges of small cubes comprising the grid change, we can quantify which parts from the brain have been enlarged, compressed or just remain the same. When the nonlinear approach is applied, scans from PD patients show a region near their striatum very similar in shape to that of healthy subjects. This artificially increases the interclass separation between patients with PD and healthy subjects as the local intensity is decreased in the latter region, and leads machine learning systems to biased results due to the artificial information introduced by these deformations.

A novel hybrid soft computing optimization framework for dynamic economic dispatch problem of complex non-convex contiguous constrained machines

The reformations of the electrical power sector have resulted in very dynamic and competitive market that has changed many elements of the power industry. Excessive demand of energy, depleting the fossil fuel reserves of planet and releasing the toxic air pollutant, has been causing harm to earth habitats. In this new situation, insufficiency of energy supplies, rising power generating costs, high capital cost of renewable energy equipment, environmental concerns of wind power turbines, and ever-increasing demand for electrical energy need efficient economic dispatch. The objective function in practical economic dispatch (ED) problem is nonlinear and non-convex, with restricted equality and inequality constraints, and traditional optimization methods are incapable of resolving such non-convex problems. Over the recent decade, meta-heuristic optimization approaches have acquired enormous reputation for obtaining a solution strategy for such types of ED issues. In this paper, a novel soft computing optimization technique is proposed for solving the dynamic economic dispatch problem (DEDP) of complex non-convex machines with several constraints. Our premeditated framework employs the genetic algorithm (GA) as an initial optimizer and sequential quadratic programming (SQP) for the fine tuning of the pre-optimized run of GA. The simulation analysis of GA-SQP performs well by acquiring less computational cost and finite time of execution, while providing optimal generation of powers according to the targeted power demand and load, whereas subject to valve point loading effect (VPLE) and multiple fueling option (MFO) constraints. The adequacy of the presented strategy concerning accuracy, convergence as well as reliability is verified by employing it on ten benchmark case studies, including non-convex IEEE bus system at the same time also considering VPLE of thermal power plants. The potency of designed optimization seems more robust with fast convergence rate while evaluating the hard bounded DEDP. Our suggested hybrid method GA-SQP converges to achieve the best optimal solution in a confined environment in a limited number of simulations. The simulation results demonstrate applicability and adequacy of the given hybrid schemes over conventional methods.

Deep Multimodal Neural Network Based on Data-Feature Fusion for Patient-Specific Quality Assurance

Patient-specific quality assurance (QA) for Volumetric Modulated Arc Therapy (VMAT) plans is routinely performed in the clinical. However, it is labor-intensive and time-consuming for medical physicists. QA prediction models can address these shortcomings and improve efficiency. Current approaches mainly focus on single cancer and single modality data. They are not applicable to clinical practice. To assess the accuracy of QA results for VMAT plans, this paper presents a new model that learns complementary features from the multi-modal data to predict the gamma passing rate (GPR). According to the characteristics of VMAT plans, a feature-data fusion approach is designed to fuse the features of imaging and non-imaging information in the model. In this study, 690 VMAT plans are collected encompassing more than ten diseases. The model can accurately predict the most VMAT plans at all three gamma criteria: 2%/2 mm, 3%/2 mm and 3%/3 mm. The mean absolute error between the predicted and measured GPR is 2.17%, 1.16% and 0.71%, respectively. The maximum deviation between the predicted and measured GPR is 3.46%, 4.6%, 8.56%, respectively. The proposed model is effective, and the features of the two modalities significantly influence QA results.

Arbitrary Scale Super-Resolution for Medical Images

Single image super-resolution (SISR) aims to obtain a high-resolution output from one low-resolution image. Currently, deep learning-based SISR approaches have been widely discussed in medical image processing, because of their potential to achieve high-quality, high spatial resolution images without the cost of additional scans. However, most existing methods are designed for scale-specific SR tasks and are unable to generalize over magnification scales. In this paper, we propose an approach for medical image arbitrary-scale super-resolution (MIASSR), in which we couple meta-learning with generative adversarial networks (GANs) to super-resolve medical images at any scale of magnification in [Formula: see text]. Compared to state-of-the-art SISR algorithms on single-modal magnetic resonance (MR) brain images (OASIS-brains) and multi-modal MR brain images (BraTS), MIASSR achieves comparable fidelity performance and the best perceptual quality with the smallest model size. We also employ transfer learning to enable MIASSR to tackle SR tasks of new medical modalities, such as cardiac MR images (ACDC) and chest computed tomography images (COVID-CT). The source code of our work is also public. Thus, MIASSR has the potential to become a new foundational pre-/post-processing step in clinical image analysis tasks such as reconstruction, image quality enhancement, and segmentation.

A Multi-Objective Evolutionary Approach Based on Graph-in-Graph for Neural Architecture Search of Convolutional Neural Networks

With the development of deep learning, the design of an appropriate network structure becomes fundamental. In recent years, the successful practice of Neural Architecture Search (NAS) has indicated that an automated design of the network structure can efficiently replace the design performed by human experts. Most NAS algorithms make the assumption that the overall structure of the network is linear and focus solely on accuracy to assess the performance of candidate networks. This paper introduces a novel NAS algorithm based on a multi-objective modeling of the network design problem to design accurate Convolutional Neural Networks (CNNs) with a small structure. The proposed algorithm makes use of a graph-based representation of the solutions which enables a high flexibility in the automatic design. Furthermore, the proposed algorithm includes novel ad-hoc crossover and mutation operators. We also propose a mechanism to accelerate the evaluation of the candidate solutions. Experimental results demonstrate that the proposed NAS approach can design accurate neural networks with limited size.

The Role of Neural Network for the Detection of Parkinson's Disease: A Scoping Review

Background: Parkinson’s Disease (PD) is a chronic neurodegenerative disorder that has been ranked second after Alzheimer’s disease worldwide. Early diagnosis of PD is crucial to combat against PD to allow patients to deal with it properly. However, there is no medical test(s) available to diagnose PD conclusively. Therefore, computer-aided diagnosis (CAD) systems offered a better solution to make the necessary data-driven decisions and assist the physician. Numerous studies were conducted to propose CAD to diagnose PD in the early stages. No comprehensive reviews have been conducted to summarize the role of AI tools to combat PD. Objective: The study aimed to explore and summarize the applications of neural networks to diagnose PD. Methods: PRISMA Extension for Scoping Reviews (PRISMA-ScR) was followed to conduct this scoping review. To identify the relevant studies, both medical databases (e.g., PubMed) and technical databases (IEEE) were searched. Three reviewers carried out the study selection and extracted the data from the included studies independently. Then, the narrative approach was adopted to synthesis the extracted data. Results: Out of 1061 studies, 91 studies satisfied the eligibility criteria in this review. About half of the included studies have implemented artificial neural networks to diagnose PD. Numerous studies included focused on the freezing of gait (FoG). Biomedical voice and signal datasets were the most commonly used data types to develop and validate these models. However, MRI- and CT-scan images were also utilized in the included studies. Conclusion: Neural networks play an integral and substantial role in combating PD. Many possible applications of neural networks were identified in this review, however, most of them are limited up to research purposes.

Neural Networks with Emotion Associations, Topic Modeling and Supervised Term Weighting for Sentiment Analysis

Automated sentiment analysis is becoming increasingly recognized due to the growing importance of social media and e-commerce platform review websites. Deep neural networks outperform traditional lexicon-based and machine learning methods by effectively exploiting contextual word embeddings to generate dense document representation. However, this representation model is not fully adequate to capture topical semantics and the sentiment polarity of words. To overcome these problems, a novel sentiment analysis model is proposed that utilizes richer document representations of word-emotion associations and topic models, which is the main computational novelty of this study. The sentiment analysis model integrates word embeddings with lexicon-based sentiment and emotion indicators, including negations and emoticons, and to further improve its performance, a topic modeling component is utilized together with a bag-of-words model based on a supervised term weighting scheme. The effectiveness of the proposed model is evaluated using large datasets of Amazon product reviews and hotel reviews. Experimental results prove that the proposed document representation is valid for the sentiment analysis of product and hotel reviews, irrespective of their class imbalance. The results also show that the proposed model improves on existing machine learning methods.

Decoding Three Different Preference Levels of Consumers Using Convolutional Neural Network: A Functional Near-Infrared Spectroscopy Study

This study decodes consumers' preference levels using a convolutional neural network (CNN) in neuromarketing. The classification accuracy in neuromarketing is a critical factor in evaluating the intentions of the consumers. Functional near-infrared spectroscopy (fNIRS) is utilized as a neuroimaging modality to measure the cerebral hemodynamic responses. In this study, a specific decoding structure, called CNN-based fNIRS-data analysis, was designed to achieve a high classification accuracy. Compared to other methods, the automated characteristics, constant training of the dataset, and learning efficiency of the proposed method are the main advantages. The experimental procedure required eight healthy participants (four female and four male) to view commercial advertisement videos of different durations (15, 30, and 60 s). The cerebral hemodynamic responses of the participants were measured. To compare the preference classification performances, CNN was utilized to extract the most common features, including the mean, peak, variance, kurtosis, and skewness. Considering three video durations, the average classification accuracies of 15, 30, and 60 s videos were 84.3, 87.9, and 86.4%, respectively. Among them, the classification accuracy of 87.9% for 30 s videos was the highest. The average classification accuracies of three preferences in females and males were 86.2 and 86.3%, respectively, showing no difference in each group. By comparing the classification performances in three different combinations (like vs. so-so, like vs. dislike, and so-so vs. dislike) between two groups, male participants were observed to have targeted preferences for commercial advertising, and the classification performance 88.4% between "like" vs. "dislike" out of three categories was the highest. Finally, pairwise classification performance are shown as follows: For female, 86.1% (like vs. so-so), 87.4% (like vs. dislike), 85.2% (so-so vs. dislike), and for male 85.7, 88.4, 85.1%, respectively.

Acrophobia Quantified by EEG Based on CNN Incorporating Granger Causality

The aim of this study is to quantify acrophobia and provide safety advices for high-altitude workers. Considering that acrophobia is a fuzzy quantity that cannot be accurately evaluated by conventional detection methods, we propose a comprehensive solution to quantify acrophobia. Specifically, this study simulates a virtual reality environment called High-altitude Plank Walking Challenge, which provides a safe and controlled experimental environment for subjects. Besides, a method named Granger Causality Convolutional Neural Network (GCCNN) combining convolutional neural network and Granger causality functional brain network is proposed to analyze the subjects' noninvasive scalp EEG signals. Here, the GCCNN method is used to distinguish the subjects with severe acrophobia, moderate acrophobia, and no acrophobia in a three-class classification task or no acrophobia and acrophobia in a two-class classification task. Compared with the mainstream methods, the GCCNN method achieves better classification performance, with an accuracy of 98.74% for the two-class classification task (no acrophobia versus acrophobia) and of 98.47% for the three-class classification task (no acrophobia versus moderate acrophobia versus severe acrophobia). Consequently, our proposed GCCNN method can provide more accurate quantitative results than the comparative methods, making it to be more competitive in further practical applications.

A Neural Network for Image Anomaly Detection with Deep Pyramidal Representations and Dynamic Routing

Image anomaly detection is an application-driven problem where the aim is to identify novel samples, which differ significantly from the normal ones. We here propose Pyramidal Image Anomaly DEtector (PIADE), a deep reconstruction-based pyramidal approach, in which image features are extracted at different scale levels to better catch the peculiarities that could help to discriminate between normal and anomalous data. The features are dynamically routed to a reconstruction layer and anomalies can be identified by comparing the input image with its reconstruction. Unlike similar approaches, the comparison is done by using structural similarity and perceptual loss rather than trivial pixel-by-pixel comparison. The proposed method performed at par or better than the state-of-the-art methods when tested on publicly available datasets such as CIFAR10, COIL-100 and MVTec.

A Swallowing Decoder Based on Deep Transfer Learning: AlexNet Classification of the Intracranial Electrocorticogram

To realize a brain-machine interface to assist swallowing, neural signal decoding is indispensable. Eight participants with temporal-lobe intracranial electrode implants for epilepsy were asked to swallow during electrocorticogram (ECoG) recording. Raw ECoG signals or certain frequency bands of the ECoG power were converted into images whose vertical axis was electrode number and whose horizontal axis was time in milliseconds, which were used as training data. These data were classified with four labels (Rest, Mouth open, Water injection, and Swallowing). Deep transfer learning was carried out using AlexNet, and power in the high-[Formula: see text] band (75-150[Formula: see text]Hz) was the training set. Accuracy reached 74.01%, sensitivity reached 82.51%, and specificity reached 95.38%. However, using the raw ECoG signals, the accuracy obtained was 76.95%, comparable to that of the high-[Formula: see text] power. We demonstrated that a version of AlexNet pre-trained with visually meaningful images can be used for transfer learning of visually meaningless images made up of ECoG signals. Moreover, we could achieve high decoding accuracy using the raw ECoG signals, allowing us to dispense with the conventional extraction of high-[Formula: see text] power. Thus, the images derived from the raw ECoG signals were equivalent to those derived from the high-[Formula: see text] band for transfer deep learning.

A Methodology to Differentiate Parkinson's Disease and Aging Speech Based on Glottal Flow Acoustic Analysis

Speech is controlled by axial neuromotor systems, therefore, it is highly sensitive to the effects of neurodegenerative illnesses such as Parkinson's Disease (PD). Patients suffering from PD present important alterations in speech, which are manifested in phonation, articulation, prosody, and fluency. These alterations may be evaluated using statistical methods on features obtained from glottal, spectral, cepstral, or fractal descriptions of speech. This work introduces an evaluation paradigm based on Information Theory (IT) to differentiate the effects of PD and aging on glottal amplitude distributions. The study is conducted on a database including 48 PD patients (24 males, 24 females), 48 age-matched healthy controls (HC, 24 males, 24 females), and 48 mid-age normative subjects (NS, 24 males, 24 females). It may be concluded from the study that Hierarchical Clustering (HiCl) methods produce a clear separation between the phonation of PD patients from NS subjects (accuracy of 89.6% for both male and female subsets), but the separation between PD patients and HC subjects is less efficient (accuracy of 75.0% for the male subset and 70.8% for the female subset). Conversely, using feature selection and Support Vector Machine (SVM) classification, the differentiation between PD and HC is substantially improved (accuracy of 94.8% for the male subset and 92.8% for the female subset). This improvement was mainly boosted by feature selection, at a cost of information and generalization losses. The results point to the possibility that speech deterioration may affect HC phonation with aging, reducing its difference to PD phonation.

Machine learning (ML) for the diagnosis of autism spectrum disorder (ASD) using brain imaging

Autism spectrum disorder (ASD) is a neurodevelopmental incurable disorder with a long diagnostic period encountered in the early years of life. If diagnosed early, the negative effects of this disease can be reduced by starting special education early. Machine learning (ML), an increasingly ubiquitous technology, can be applied for the early diagnosis of ASD. The aim of this study is to examine and provide a comprehensive state-of-the-art review of ML research for the diagnosis of ASD based on (a) structural magnetic resonance image (MRI), (b) functional MRI and (c) hybrid imaging techniques over the past decade. The accuracy of the studies with a large number of participants is in general lower than those with fewer participants leading to the conclusion that further large-scale studies are needed. An examination of the age of the participants shows that the accuracy of the automated diagnosis of ASD is higher at a younger age range. ML technology is expected to contribute significantly to the early and rapid diagnosis of ASD in the coming years and become available to clinicians in the near future. This review is aimed to facilitate that.

Medical Image Fusion Method Based on Coupled Neural P Systems in Nonsubsampled Shearlet Transform Domain

Coupled neural P (CNP) systems are a recently developed Turing-universal, distributed and parallel computing model, combining the spiking and coupled mechanisms of neurons. This paper focuses on how to apply CNP systems to handle the fusion of multi-modality medical images and proposes a novel image fusion method. Based on two CNP systems with local topology, an image fusion framework in nonsubsampled shearlet transform (NSST) domain is designed, where the two CNP systems are used to control the fusion of low-frequency NSST coefficients. The proposed fusion method is evaluated on 20 pairs of multi-modality medical images and compared with seven previous fusion methods and two deep-learning-based fusion methods. Quantitative and qualitative experimental results demonstrate the advantage of the proposed fusion method in terms of visual quality and fusion performance.

Morphological Characterization of Functional Brain Imaging by Isosurface Analysis in Parkinson’s Disease

Finding new biomarkers to model Parkinson’s Disease (PD) is a challenge not only to help discerning between Healthy Control (HC) subjects and patients with potential PD but also as a way to measure quantitatively the loss of dopaminergic neurons mainly concentrated at substantia nigra. Within this context, this work presented here tries to provide a set of imaging features based on morphological characteristics extracted from I[Formula: see text]-Ioflupane SPECT scans to discern between HC and PD participants in a balanced set of [Formula: see text] scans from Parkinson’s Progression Markers Initiative (PPMI) database. These features, obtained from isosurfaces of each scan at different intensity levels, have been classified through the use of classical Machine Learning classifiers such as Support-Vector-Machines (SVM) or Naïve Bayesian and compared with the results obtained using a Multi-Layer Perceptron (MLP).

The proposed system, based on a Mann–Whitney–Wilcoxon U-Test for feature selection and the SVM approach, yielded a [Formula: see text] balanced accuracy when the performance was evaluated using a [Formula: see text]-fold cross-validation. This proves the reliability of these biomarkers, especially those related to sphericity, center of mass, number of vertices, 2D-projected perimeter or the 2D-projected eccentricity, among others, but including both internal and external isosurfaces.

Behavioral Activity Recognition Based on Gaze Ethograms

Noninvasive behavior observation techniques allow more natural human behavior assessment experiments with higher ecological validity. We propose the use of gaze ethograms in the context of user interaction with a computer display to characterize the user's behavioral activity. A gaze ethogram is a time sequence of the screen regions the user is looking at. It can be used for the behavioral modeling of the user. Given a rough partition of the display space, we are able to extract gaze ethograms that allow discrimination of three common user behavioral activities: reading a text, viewing a video clip, and writing a text. A gaze tracking system is used to build the gaze ethogram. User behavioral activity is modeled by a classifier of gaze ethograms able to recognize the user activity after training. Conventional commercial gaze tracking for research in the neurosciences and psychology science are expensive and intrusive, sometimes impose wearing uncomfortable appliances. For the purposes of our behavioral research, we have developed an open source gaze tracking system that runs on conventional laptop computers using their low quality cameras. Some of the gaze tracking pipeline elements have been borrowed from the open source community. However, we have developed innovative solutions to some of the key issues that arise in the gaze tracker. Specifically, we have proposed texture-based eye features that are quite robust to low quality images. These features are the input for a classifier predicting the screen target area, the user is looking at. We report comparative results of several classifier architectures carried out in order to select the classifier to be used to extract the gaze ethograms for our behavioral research. We perform another classifier selection at the level of ethogram classification. Finally, we report encouraging results of user behavioral activity recognition experiments carried out over an inhouse dataset.

Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts

Rationale

In Parkinson’s disease (PD), spatial covariance analysis of ¹⁸F-FDG PET data has consistently revealed a characteristic PD-related brain pattern (PDRP). By quantifying PDRP expression on a scan-by-scan basis, this technique allows objective assessment of disease activity in individual subjects. We provide a further validation of the PDRP by applying spatial covariance analysis to PD cohorts from the Netherlands (NL), Italy (IT), and Spain (SP).

Methods

The PDRP_NL was previously identified (17 controls, 19 PD) and its expression was determined in 19 healthy controls and 20 PD patients from the Netherlands. The PDRP_IT was identified in 20 controls and 20 “de-novo” PD patients from an Italian cohort. A further 24 controls and 18 “de-novo” Italian patients were used for validation. The PDRP_SP was identified in 19 controls and 19 PD patients from a Spanish cohort with late-stage PD. Thirty Spanish PD patients were used for validation. Patterns of the three centers were visually compared and then cross-validated. Furthermore, PDRP expression was determined in 8 patients with multiple system atrophy.

Results

A PDRP could be identified in each cohort. Each PDRP was characterized by relative hypermetabolism in the thalamus, putamen/pallidum, pons, cerebellum, and motor cortex. These changes co-varied with variable degrees of hypometabolism in posterior parietal, occipital, and frontal cortices. Frontal hypometabolism was less pronounced in “de-novo” PD subjects (Italian cohort). Occipital hypometabolism was more pronounced in late-stage PD subjects (Spanish cohort). PDRP_IT, PDRP_NL, and PDRP_SP were significantly expressed in PD patients compared with controls in validation cohorts from the same center (P < 0.0001), and maintained significance on cross-validation (P < 0.005). PDRP expression was absent in MSA.

Conclusion

The PDRP is a reproducible disease characteristic across PD populations and scanning platforms globally. Further study is needed to identify the topography of specific PD subtypes, and to identify and correct for center-specific effects.

Electronic supplementary material

The online version of this article (10.1007/s00259-019-04570-7) contains supplementary material, which is available to authorized users.